跳至主要内容
临床试验/NCT00356967
NCT00356967已完成3 期

An International 7-Week, Double-Blind, Placebo-Controlled, 2-Parallel Group Study to Assess the Efficacy of Dianicline 40 mg BID as an Aid to Smoking Cessation in Cigarette Smokers

Sanofi6 个研究点 分布在 6 个国家目标入组 602 人开始时间: 2006年6月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Sanofi
入组人数
602
试验地点
6
主要终点
to assess the continuous abstinence from tobacco smoking at every visit during the last four weeks of treatment through direct inquiry of patients

研究概览

简要总结

The primary objective is to demonstrate the efficacy of dianicline as an aid to smoking cessation in cigarette smokers. The main secondary objectives are: to assess the craving for cigarettes, nicotine withdrawal symptoms and the safety of dianicline.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Outpatients over the legal age smoking at least 10 cigarettes per day for at least 2 months

排除标准

  • •Insufficient level of motivation
  • •Another participant in the household
  • •Patients with current psychotic disorder or major depressive disorder
  • •The investigator will evaluate whether there are other reasons why a patient may not participate.

结局指标

主要结局

to assess the continuous abstinence from tobacco smoking at every visit during the last four weeks of treatment through direct inquiry of patients

exhaled carbon monoxide testing

and plasma cotinine measurements

次要结局

  • questionnaire of smoking urge
  • Hughes and Hatsukami Minnesota Withdrawal Scale to measure nicotine withdrawal

研究者

发起方
Sanofi
申办方类型
Industry

研究点 (6)

Loading locations...

相似试验